Search everything:
Search Herts....
close

Book your Open Day

Postgraduate Open Day

Find out more about your course of interest, speak with our academics and discover the opportunities that further study has to offer at our Postgraduate Open Day.

Our next Postgraduate Open Day will be on Saturday 23 November 2024 from 11.00 - 15.00. We offer a range of discounts to help with travel costs.

Visit Herts to learn about:

  • Your chosen course: Speak to our friendly teaching staff about courses, module content and delivery methods
  • Employment prospects: Understand work placement opportunities, industry connections, and course accreditations
  • Support services: Get all the information you need about admissions, accommodation and student finance
  • Life at Herts: Hear from our students about their postgrad student experience at Herts
  • Explore: Discover our campuses, facilities and accommodation

Book your open day below.

close

Apply now

MSc Cancer Immunotherapy with Advanced Research

Why choose Herts?

Teaching Excellence: You will be taught by Internationally renowned researchers who support with research projects in Cancer Immunotherapy.

Employment Prospects: Graduates work as research scientists, scientific officers, and senior managers for organisations including Roche, Merck, and Astra Zeneca.

Sector-led Course Content: Explore our research interests of the Bioscience Research Group covering topics such as Adoptive T cell therapy, tumour-associated macrophages, NK cells, and monoclonal antibodies in cancer therapy.

  • Entry requirements and key information

    The normal entry requirements for the programme are:

    • An Honours Degree in Biomedical and related sciences with a background in molecular biology, genetics and immunology with a final classification grade of a minimum 60% with evidence of having completed a research project and practical experience in a range of laboratory techniques relevant to the course, such as cell culture, DNA extraction, PCR and gel electrophoresis
    • A professional qualification accepted as equivalent to the above; or
    • A qualification in veterinary science, medicine or dentistry; or
    • A first or second class Honours Degree in disciplines other than those described above but where the applicant, in the opinion of the Programme Leader, would benefit from, and succeed on, the programme
    • Students will be selected through interview.

    In addition, all international students are required to demonstrate an English Language capability of IELTS 6.5 (with no less than 6.0 in any band) or equivalent qualification.

    Institution code

    		 H36

    School of study

    		 School of Life and Medical Sciences

    Course length
  • Full Time, 2 Years
    		•

    Location
  • University of Hertfordshire, Hatfield
    		•
  • Employability

    What job can I get?

    You could make a valuable contribution to the ambitious work of cancer immunologists and play a key role in the activation of immune effector mechanisms for cancer therapy. Your skills and knowledge will be sought after in a range of careers in the immunotherapy industries. For example, Roche, Merck, Astra Zeneca and small to medium-sized enterprises. You could work in medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law. Alternatively, you may use your MSc Cancer Immunotherapy with Advanced Research to underpin an application to study for a research degree such as MRes, MSc by Research, or a PhD in a related field.

Professional Accreditations

Subject to validation, this course will be accredited by the Royal Society for Biology Accreditation.

About the course

The use of the immune system in cancer therapy is a prevailing ambition in the field. You’ll gain expert knowledge of the numerous ways cancers and the immune system interact so you can learn how cancer immunotherapies are developed. We’ll provide a thorough understanding of immune effector mechanisms and cancer biology. You’ll develop a range of personal skills through self-directed learning and our problem-based approach to teaching.

Alternatively, consider taking our other MSc Cancer Immunotherapy routes:

Why choose this course?

  • 92% overall satisfaction for Medicine and Dentistry in the Postgraduate Taught Experience Survey (PTES, 2024)
  • You’ll be taught by our expert staff and innovative speakers from the biopharmaceutical industry
  • Our modern Science Building provides excellent facilities for laboratory experiments, including DNA and genomic analysis eg QPCR, protein and proteomic science (eg MALDI-ToF), cell culture and Enzyme-based assays, isolated tissue studies and immunohistochemistry
  • When you graduate, you’ll be equipped to work in a broad range of fields including medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law
  • We adopt a blended learning approach to teaching, focussing on problem-based scenarios so you can develop strong critical analysis skills. You’ll benefit from exposure to practical techniques and guaranteed laboratory-based research projects
  • If successful, you will have the opportunity to undertake an extended 12-month research project
  • Allied Health was ranked in the top 25% of UK universities for research impact (Research Excellence Framework, 2021). 

What will I study?

You’ll benefit from the research interests of the Bioscience Research Group. These include studies of the tumour microenvironment and communication with infiltrating immune cells, the methods tumours employ to diminish the effectivity of immune effector mechanisms and how tumours communicate using extracellular vesicles with pre-metastatic sites. We’ll cover topics such as adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade.

Teaching will be delivered through lectures, tutorials and practical classes. You’ll immerse yourself in a research project which utilises problem-based and self-directed learning. You’ll explore case studies to gain a strong critical understanding. Through your research projects, carried out in our innovative Science Building and supervised by world-leading researchers, you’ll be trained in data collection, analysis and its interpretation. You’ll also benefit from expert external speakers from the biopharmaceutical industry.

  • Level 7
    ModuleCreditsCompulsory/optional
    Translational Medical Science30 CreditsCompulsory
    Contemporary Topics in Cancer Immunotherapy30 CreditsCompulsory
    Molecular Medicine30 CreditsCompulsory
    Molecular Cell Biology and Immunology30 CreditsCompulsory
    Research Internship30 CreditsCompulsory
    Extended Research Project75 CreditsCompulsory
    Research Methods15 CreditsCompulsory

    • Key staff

    Dr David Prowse

    Find out more about Dr David Prowse

    Dr Madhu Goyal
    Programme Leader

    Dr Shoib Siddiqui
    Deputy Programme Leader

    Further course information

    Course fact sheets
    MSc Cancer Immunotherapy - Extended (Revised 2024) Download
    Programme specifications
    MSc Cancer Immunotherapy - Extended (Revised 2024) Download
    Additional information

    Sandwich placement or study abroad year

    n/a

    Applications open to international and EU students

    		 Yes

    Student experience

    At the University of Hertfordshire, we want to make sure your time studying with us is as stress-free and rewarding as possible. We offer a range of support services including; student wellbeing, academic support, accommodation and childcare to ensure that you make the most of your time at Herts and can focus on studying and having fun.

    Find out about how we support our students

    You can also read our student blogs to find out about life at Herts.